Rachna Talati
Biography
Overview
Rachna Talati is an associate in the Firm's Capital Markets group based in Singapore. She regularly advises underwriters and issuers on various equity and debt capital markets offerings, including IPOs, rights offerings, qualified institutional placements (QIP), and bond issuances, as well as block trades.
Experience
Rachna's recent experience includes advising:
The book running lead managers in relation to the IPO of Niva Bupa Health Insurance Company Limited, one of India's largest and fastest growing standalone retail health insurers, and the only health insurance company in India that is majority controlled by a foreign global healthcare group, Bupa.
The book running lead managers on Hyundai Motor India Limited's Rule 144A/Regulation S IPO, which is the largest in Indian history, the world's second-largest IPO in 2024 to date and Hyundai Motor's first listing outside Korea.
Certain selling shareholders in their exit through the Rule 144A IPO of Northern Arc Limited, a diversified financial services platform set up primarily with the mission of catering to the diverse retail credit requirements of the under-served households and businesses in India.
The book running lead managers on the Regulation S IPO of Awfis Space Solutions Limited, the largest flexible workspace solutions company in India.
The book running lead managers on the US$360 million IPO of Aadhar Housing Finance Limited, a Blackstone portfolio company focused on the low-income housing segment in India.
The book running lead managers on the proposed IPO of SK Finance Ltd., a finance company aiming to provide last-mile coverage to unbanked customers.
The book running lead managers on the 144A IPO of Fedbank Financial Services Limited, a retail focused non-banking finance company.
The book running lead managers on the US$235 million 144A IPO of R R Kabel Limited, a leading Indian wire and cable supplier backed by TPG Asia VII SF Pte. Ltd.
The book running lead manager on the US$126 million Regulation S rights issue of Piramal Pharma Limited.
The book running lead managers on the US$279 million 144A institutions placement by Brookfield India Real Estate Trust, India's first institutionally managed public commercial real estate vehicle. Brookfield India Real Estate Trust is sponsored by an affiliate of Brookfield Corporation.
